2018
DOI: 10.1177/0004563218795212
|View full text |Cite
|
Sign up to set email alerts
|

A two-step homogeneous assay for apolipoprotein E-containing high-density lipoprotein-cholesterol

Abstract: Background Apolipoprotein E-containing high-density lipoprotein shows antiatherogenic properties in vitro. There is a need for a homogeneous assay to determine the concentration of apolipoprotein E-containing high-density lipoprotein for in vivo studies. Methods In the proposed homogeneous assay, lipoproteins other than apolipoprotein E-containing high-density lipoprotein were eliminated in the first step. Apolipoprotein E-containing high-density lipoprotein-cholesterol was measured in the second step. The con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 33 publications
(59 reference statements)
0
2
0
Order By: Relevance
“…Serum creatinine, liver transaminases, TC, TG, HDL-C, HDL3-C, apoE-HDL-C, direct LDL-C, sdLDL-C, LDL-TG, and RLP-C were measured by automated standardized enzymatic analysis on a Cobas C501 analyzer (Roche Diagnostics, Germany). The specialized lipid assay kits were provided by the Denka-Seiken Corporation (Tokyo, Japan) as previously described 24, 31, 32, 3843) . All specialized lipid assays had within and between run CVs were < 6.0%, and in most cases < 3.0%.…”
Section: Methodsmentioning
confidence: 99%
“…Serum creatinine, liver transaminases, TC, TG, HDL-C, HDL3-C, apoE-HDL-C, direct LDL-C, sdLDL-C, LDL-TG, and RLP-C were measured by automated standardized enzymatic analysis on a Cobas C501 analyzer (Roche Diagnostics, Germany). The specialized lipid assay kits were provided by the Denka-Seiken Corporation (Tokyo, Japan) as previously described 24, 31, 32, 3843) . All specialized lipid assays had within and between run CVs were < 6.0%, and in most cases < 3.0%.…”
Section: Methodsmentioning
confidence: 99%
“…The incremental area under the curve (iAUC) was calculated by subtracting fasting AUC from total AUC. sdLDL-C 5) , LDL-TG 9) , HDL3-C 20) , apoE-rich HDL-C 21) , and remnant-like particle (RLP)-C 22) were measured by the homogeneous method (Denka Co., Ltd. Tokyo, Japan). TRL-C was measured directly by the homogeneous method (Denka Co., Ltd.) using a twostep process where LDL and HDL are degraded, and lipoprotein spectrums from TG-rich lipoproteins (TRLs) to HDL 3) .…”
Section: Methodsmentioning
confidence: 99%